Avanir unveils promising drugs for atherosclerosis
Avanir Pharmaceuticals has discovered a series of orally-active small molecules that, in animal models, reduce the fatty deposits in blood vessel walls typically associated with atherosclerosis.
Archives for March 16, 2004
Novartis considering white knight bid for Aventis
Switzerland's Novartis has confirmed that it is in discussions with Aventis which could lead to a counter-offer to fend off the hostile takeover bid from France's Sanofi-Synthelabo.
Chip scales down nucleic acid extraction
Scientists at the California Institute of Technology in the US have developed a postage stamp-sized chip that can be used to carry out many of the routine steps involved in isolating and purifying nucleic acids from cells.